By Louis Navellier of InvestorPlace
In a world that usually speaks in complex numbers and figures, when it comes to mapping out the market recovery Wall Street speaks in alphabetical letters -- such as W, V, U and L.
It's fascinating to chart lovers like me. It all has to do with defining the "shape" of the U.S. market recovery. Will it go up in a straight line? Or will it drift downward first before a sustained upward trend?
In March, the debate heated up, but please don't let all this rhetoric distract you. It's much more important to focus on the stocks you own than on the shape of things to come. If you own the very best stocks, you will secure your financial future no matter what happens on Wall Street.
More From Investor Place
And following are my top five stocks for April to help you do just that.
Top Stock No. 1: Colgate-Palmolive
Colgate-Palmolive boasts a line of personal care products that continue to be brisk sellers even amid weaker consumer spending. That helped the company boost fourth-quarter profit by a healthy 27% compared with the previous year. Product price increases boosted margins and revenue climbed more than 11% to top $4 billion.
If you read my
article a few weeks back, I'm sure you noticed there was a distinct global flavor to the list. That's because global consumer spending is strong even if unemployment in the U.S. remains troublesome. While it's true that CL operates out of a Park Avenue office in New York, this multinational blue-chip has a global footprint that is allowing it to cash in on these opportunities with the best of them.
Top Stock No. 2: Express Scripts
Express Scripts is a North American provider of pharmacy benefit-management services. Some of its customers include third-party administrators, health insurers and employers. Besides providing customers with home delivery, benefit design consultation and disease management services, to name a few, it also provides various specialty services like patient care, marketing and customized logistics solutions.
With the Democrats running through health care reform no matter what -- and regardless of how you feel about the process -- you have to admit that broader coverage means more customers for drug stocks like Express Scripts.
Top Stock No. 3: Seagate Technology
Seagate Technology is a leading manufacturer of hard drives used in a wide variety of gadgets from personal computers and consumer electronics to high-end servers and mainframes. About two-thirds of Seagate's sales are to computer hardware manufacturers, which include
, while distributors and retailers account for the rest. Approximately, 75% of Seagate's sales are to manufacturers outside the U.S., making it a true industry leader with a wide market share and many revenue streams.
On Jan. 21, the company reported that its latest quarter sales surged 33% to $3.03 billion. Thanks to this performance, the company posted a whopping 55.4% earnings surprise and a 6.3% sales surprise.
Top Stock No. 4: Ford
Ford continues to gobble up market share from defunct Detroit automakers
. And now, Ford is giving
a run for its money in the wake of some very costly recall announcements for the Japanese auto giant.
In early February, Ford announced that its January sales jumped 25%. Then in the first week of March, Ford posted a 43% surge in its February U.S. sales. The company also set higher second-quarter production targets for North America.
I recommend you buy Ford stock as long as it is less than $18 a share. Shares are up over six-fold from their lows in March 2009, but there is a lot of room left to run for this company.
Top Stock No. 5: Priceline.com
Priceline.com has won over consumers by allowing buyers to name their own price for everything from airline tickets to rental cars to cruises. Priceline.com keeps the difference between the price paid by the individual and what PCLN has paid for the ticket or hotel room.
In mid-February, the company said that its quarterly profit more than doubled with strong earnings of $78.5 million, and sales jumped by a whopping 33%. As a result, shares skyrocketed 9% the following day alone. This is the type of explosive performance you can expect from this breakout small-cap stock in the months ahead.
At the time of publication, Navellier had positions in Ford, Priceline.com, Colgate-Palmolive and Express Scripts.
One of Wall Street's renowned growth investors, Louis Navellier is the editor of four investing newsletters: Emerging Growth (formerly known as MPT Review), Blue Chip Growth, Quantum Growth and Global Growth. His longest-running publication, Emerging Growth, has a track record of beating the market nearly 3 to 1. Navellier is the author of a BusinessWeek bestseller, "The Little Book That Makes You Rich," and the chairman and founder of Navellier & Associates, Inc.